1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ares Acquisition Corporation III, a blank check company, completed its initial public offering on July 1, 2026, selling 39,500,000 units at $10.00 each for gross proceeds of $395 million, including 5,000,000 units from partial exercise of the underwriters' over-allotment option. A total of $406.2 million, including $11.2 million from the sponsor's private placement of warrants, was deposited into a trust account, which generally cannot be released until a business combination, a shareholder vote on charter changes, or a redemption of public shares.
IPO of 39,500,000 units at $10.00 per unit on July 1, 2026, generating gross proceeds of $395 million
Sponsor purchased 7,466,667 private placement warrants at $1.50 each, for $11.2 million
$406.2 million placed in trust account at JPMorgan Chase Bank, with Continental Stock Transfer & Trust Company as trustee
Public warrants exercisable at $11.50 per share; sponsor office and administrative fee is $16,667 per month
Neurogene agreed on June 30, 2026 to sell 3,500,000 common shares at $30.00 each, with pre-funded warrants for up to 666,666 more shares offered in place of common stock for some investors. Underwriters exercised in full their option to buy 624,999 additional shares on July 1, 2026, and the company expects net proceeds of about $134.8 million. The company says these proceeds, plus existing cash, will fund operations into the first quarter of 2029, but the sale adds new shares outstanding for existing shareholders.
3,500,000 common shares offered at $30.00 per share, plus pre-funded warrants for up to 666,666 shares
Underwriters exercised in full their option for up to 624,999 additional shares on July 1, 2026
Expected net proceeds of approximately $134.8 million after underwriting discounts and estimated expenses
Offering expected to close July 2, 2026; company expects cash to last into the first quarter of 2029
On June 30, 2026, Jackson Financial entered a revolving credit agreement with aggregate commitments of $1.25 billion, led by Wells Fargo as administrative agent. The new agreement replaces the company's $1 billion 2023 credit facility, which was scheduled to terminate in February 2028, and the filing describes its covenants as substantially similar to that earlier agreement.
Aggregate commitments of $1.25 billion, with a $500 million sub-limit for letters of credit and a possible increase of up to $500 million on request
Replaces the $1 billion credit agreement dated February 24, 2023, which was scheduled to terminate in February 2028
Commitments terminate June 30, 2031, with two one-year extension options subject to required bank approval
Borrowings are unsecured, priced at Term SOFR plus 1.125% to 1.875% or Base Rate plus 0.125% to 0.875%, based on the company's senior debt ratings
Hims & Hers subsidiaries XeCare LLC and Apostrophe Pharmacy LLC entered a Master Receivables Purchase Agreement with JPMorgan Chase Bank on July 1, 2026, allowing them to sell eligible receivables for cash, subject to a $400 million facility limit. The company also agreed to guarantee the sellers' performance under the agreement, though not the collectability of the receivables, and amended its credit agreement to permit the arrangement.
Facility limit for eligible receivables is $400 million, with an initial term of 364 days that may be extended.
The company guarantees the sellers' performance under the agreement but not receivable collectability or seller creditworthiness.
Amendment No. 4 to the Revolving Credit and Guaranty Agreement, dated June 26, 2026, adds a $400 million debt basket for this arrangement.
The filing does not disclose the purchase discount or any financial results tied to the arrangement.
Nasdaq, Inc. entered into an amended and restated credit agreement on June 30, 2026, providing a $1.5 billion senior unsecured five-year revolving credit facility that replaces its existing 2022 credit agreement as amended. As of July 1, 2026, no loans were outstanding, and the facility matures on June 30, 2031, so the filing mainly refinances existing borrowing capacity rather than adding new debt today.
Kohl's amended its revolving credit facility with Wells Fargo Bank as agent on June 30, 2026, extending the maturity by five years to June 30, 2031. The amendment also changes borrowing costs and borrowing base terms, including a new in-transit inventory basket capped at 15% of the borrowing base.
Maturity extended five years from the effective date of the amendment to June 30, 2031
Applicable Margin now ranges from 0.25% to 0.50% for Base Rate Loans and 1.25% to 1.50% for SOFR Loans, using a single 50% availability breakpoint
Removed the prior 0.10% credit spread adjustment from Term SOFR; in-transit inventory may count up to 15% of the borrowing base
On June 29, 2026, Avis Budget Group and subsidiaries Avis Budget Holdings, LLC and Avis Budget Car Rental, LLC entered an Eleventh Amendment to their Sixth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment replaces the existing $2 billion revolving facility with a new $2 billion facility and adds a new $200 million revolving facility, both with springing maturities tied to other debt and legal settlement proceeds. The filing does not state pricing, drawn balances or the prior maturity date.
New $2 billion revolving facility (2031 Revolving Facility) matures June 29, 2031, with a springing maturity 90 days before certain long-term debt maturities if that debt exceeds $300 million
New $200 million revolving facility (2028 Revolving Facility) matures June 29, 2028
Amendment closed June 29, 2026; the 8-K was filed July 1, 2026 with the agreement attached as Exhibit 10.1
Exozymes sold 71,110 shares and 35,555 warrants to one investor on June 30, 2026, for gross proceeds of $639,990 before about $74,799 in commissions and other expenses. The company says net proceeds will fund its NCT business and products, next-in-line products, research and development, and general corporate purposes. The warrants include a reset to $0.001 if the company sells shares below $8.99 before June 5, 2027, which could dilute existing holders.
Gross proceeds of $639,990, with commissions of $44,799 and other expenses of approximately $30,000
Each $18.00 unit included one share valued at $8.99 and one warrant valued at $0.02
Warrants are exercisable at $11.24 from June 5, 2027, to June 5, 2031, and reset to $0.001 on certain lower-priced sales before June 5, 2027
MDB Capital, the placement agent, received a warrant to buy 10,666 shares at $11.24
On June 29, 2026, Mama's Creations agreed to sell 5,555,556 shares of common stock at $18.00 each, with gross proceeds of approximately $100 million before fees. The offering was completed July 1, 2026, with net proceeds of approximately $94.0 million, which the company intends to use for working capital, general corporate purposes and possibly acquisitions with no current agreements. New shares dilute existing holders, and the company's filing also updates risk factors on integrating the Crown I Carve Out Business.
5,555,556 shares sold at $18.00 per share; gross proceeds of approximately $100 million before fees.
Underwriters have a 30-day option to buy up to 833,333 more shares; full exercise would bring gross proceeds to about $115 million.
Offering completed July 1, 2026; net proceeds of approximately $94.0 million for working capital and general corporate purposes.
Risk factor update on integrating the Crown I Carve Out Business, acquired September 2, 2025.
On July 1, 2026, Qnity Electronics entered into Repricing Amendment No. 1 to its October 31, 2025 credit agreement with JPMorgan Chase Bank, N.A. The amendment lowers the interest margin on all $2,338,250,000 of outstanding term loans, and the company says other loan terms are not materially changed. Lower borrowing costs can help free cash for shareholders, though the filing does not quantify the savings.
All $2,338,250,000 of term loans outstanding before July 1, 2026 were repriced.
Term SOFR margin falls from 2.00% to 1.75%; Base Rate Loan margin falls from 1.00% to 0.75%.
A 1.00% premium applies to certain repricing-related prepayments or amendments through six months after the closing date.
Other terms, including maturity, security and covenants, are described as materially unchanged.
Viatris entered into an amended and restated term loan credit agreement on July 1, 2026, providing a ¥40 billion senior unsecured term loan facility with Mizuho Bank, Ltd. as administrative agent. The filing says proceeds will be used in part to repay the prior ¥40 billion unsecured term loan dated July 1, 2021, so the facility replaces existing debt of the same stated amount rather than adding a new borrowing of that size.
Facility amount is ¥40 billion, the same principal as the prior term loan dated July 1, 2021, which the proceeds are partly used to repay.
Interest is set at the TIBO Rate plus 1.10% per annum initially, with the margin able to change based on Viatris's credit ratings from S&P Global Ratings, Moody's and Fitch.
Borrowings are due three years from the July 1, 2026 Closing Date and include a leverage ratio covenant of no greater than 3.75 to 1.00 at each fiscal quarter end.
Mylan Inc., Utah Acquisition Sub Inc. and Mylan II B.V. guarantee the facility as of the Closing Date.
On June 30, 2026, Evergy and three utility subsidiaries entered a credit agreement allowing up to $3.5 billion in aggregate borrowings, maturing June 30, 2031. The same day, they terminated a $2.5 billion credit agreement due August 31, 2028 and a $1 billion delayed draw term loan due August 10, 2026, with no early termination penalties. The filing does not state borrowing costs, so the financial effect for shareholders is not quantified beyond the facility size and terms.
Credit facility allows maximum borrowings of up to $3.5 billion, with sublimits of $200 million for letters of credit and $250 million for swingline loans
Matures June 30, 2031; borrowers may extend on up to two occasions for one-year terms and may increase commitments by up to $1 billion
Terminated the $2.5 billion credit agreement dated August 31, 2021 and the $1 billion delayed draw term loan dated May 5, 2026, with no early termination penalties
World Acceptance Corporation entered into an accordion increase under its revolving credit agreement on June 29, 2026, adding a $15.0 million commitment from Investar Bank, National Association. Aggregate lender commitments rose from $640.0 million to $655.0 million, giving the company more borrowing capacity under a routine financing arrangement.
Accordion increase of $15.0 million from Investar Bank, National Association, dated June 29, 2026
Aggregate commitments under the revolving credit agreement rose from $640.0 million to $655.0 million
Company agreed to pay an upfront fee of 0.15% of the Increasing Lender's commitment and issued a $15.0 million revolving credit note
Crescent Capital BDC, Inc. exercised its option on June 29, 2026 to prepay $50.0 million of 7.54% senior unsecured notes that were due July 28, 2026. The company paid about $51.6 million, covering the principal and accrued, unpaid interest through the prepayment date. The filing says none of the notes remain outstanding, which removes that debt before its scheduled maturity.
Prepaid principal: $50.0 million of 7.54% senior unsecured notes
Original maturity date: July 28, 2026
Total amount paid: about $51.6 million, including accrued and unpaid interest
Prepayment date: June 29, 2026; notes now fully repaid
Flexible Solutions International signed an at-the-market sales agreement with Bancroft Capital on June 30, 2026, allowing it to sell common stock worth up to $18.5 million through the agent. The company will pay Bancroft a 3% cash fee on gross proceeds, plus expense reimbursement up to $30,000 and up to $5,000 per quarter, so new shares could dilute existing holders.
Agreement dated June 30, 2026, with Bancroft Capital, LLC as sales agent for up to $18,500,000 of common stock
Shares sold under effective Form S-3 (Registration No. 333-293705), declared effective March 5, 2026
Cash fee of 3% of gross proceeds, plus expense reimbursement up to $30,000 and up to $5,000 per quarter
On June 29, 2026, Vishay agreed to sell 15,000,000 common shares at $50.00 each, and underwriters exercised in full their option to buy 2,250,000 more on June 30. The company expects net proceeds of about $830.3 million, to be used for growth initiatives, general corporate purposes and reducing borrowings under its senior secured credit facility. The sale adds to the number of shares outstanding, and closing is expected on July 1, 2026.
15,000,000 shares offered at $50.00 per share, with J.P. Morgan Securities LLC as representative of the underwriters
Underwriters exercised in full their 30-day option for 2,250,000 additional shares on June 30, 2026
Expected net proceeds of about $830.3 million, to fund growth initiatives and reduce senior secured credit facility borrowings
Offering expected to close July 1, 2026, subject to customary closing conditions
On June 30, 2026, FTI Consulting entered into a Third Amendment and Restatement Agreement with a lender syndicate led by Bank of America, N.A. The revolving credit facility rises from $900.0 million to $1.5 billion, and its maturity moves from November 21, 2027 to June 30, 2031. The company says the changes give it more financial flexibility and better ratings-based pricing, which may matter to shareholders as added borrowing capacity and longer debt maturities.
Revolving facility increased from $900.0 million to $1.5 billion; obligations are unsecured and guaranteed by certain material wholly-owned domestic subsidiaries.
Maturity extended from November 21, 2027 to June 30, 2031.
Incremental facilities of up to the greater of $500.0 million and 100% of consolidated EBITDA are permitted, subject to a net leverage ratio of no more than 4.00 to 1.00.
The existing $300.0 million term loan, due March 17, 2029, remains outstanding under the new agreement.
On June 26, 2026, Owlet and its subsidiary Owlet Baby Care entered a $25 million asset-based revolving credit facility with Wells Fargo, which refinanced the subsidiary's existing ABL line of credit and WTI term loan. The company's press release says the new margin of SOFR plus 2.00% to 2.25% is well below the previous SOFR plus 7.50% to 8.50%, and it reports total liquidity of about $33.8 million as of June 26, 2026. The facility is secured by substantially all personal property assets and guaranteed by Owlet, and it carries a $7.5 million minimum liquidity covenant and EBITDA thresholds.
New $25 million revolving facility with Wells Fargo dated June 26, 2026; can be increased to $35 million with lender approval
OBCI drew $17,063,000 on June 26, 2026 and used the proceeds to repay the ABL line of credit and WTI term loan
Margin falls to SOFR plus 2.00% to 2.25%, versus SOFR plus 7.50% to 8.50% on the previous ABL facility, per the press release
Facility matures on the third anniversary of June 26, 2026; requires at least $7.5 million of liquidity at all times
On June 30, 2026, FMC agreed to sell 30,319,166 shares of common stock to Tessenderlo Group NV at $13.30 per share, for an aggregate purchase price of $403,244,907.80, subject to customary conditions including regulatory approvals. After closing, Tessenderlo is expected to own about 20.0% of FMC's outstanding shares, up from less than 1.0% today, and FMC intends to use the proceeds to pay down debt toward its approximately $1 billion target.
30,319,166 shares sold at $13.30 each, for an aggregate $403,244,907.80, with closing subject to regulatory approvals
Tessenderlo expected to hold about 20.0% of outstanding shares after closing, versus less than 1.0% now
Investor agreement gives Tessenderlo one board seat while it holds at least 10.0%, and a 36-month lock-up on transfers
Proceeds go to debt paydown toward an approximately $1 billion target; FMC says this concludes its strategic options review announced in February 2026
Metallus Inc. entered into a Fifth Amended and Restated Credit Agreement on June 30, 2026, with JPMorgan Chase Bank, N.A. as administrative agent, providing a $300.0 million asset-based revolving credit facility that replaces a credit agreement dated September 30, 2022. The facility matures June 30, 2031 and is secured by substantially all of the company's and its subsidiary guarantors' personal property, so it adds secured borrowing capacity while also adding covenants that restrict liens, investments, additional debt and distributions to shareholders.
Credit facility of $300.0 million, with a $15.0 million letter of credit sublimit and a $40.0 million swingline sublimit
Company may request up to $200.0 million in commitment increases on up to four occasions, plus a separate $30.0 million first-in, last-out tranche, subject to conditions
Borrowing availability depends on a borrowing base of eligible receivables, inventory and machinery and equipment; $5.3 million of letters of credit were outstanding as of June 30, 2026
Facility matures June 30, 2031; interest is based on Adjusted Term SOFR or Alternate Base Rate plus a margin, with a 0.25% unused commitment fee
Peabody Energy entered into Amendment No. 3 to its revolving credit agreement with PNC Bank, National Association, as administrative agent, on June 30, 2026. The amendment increases revolving commitments by $80 million, extends the maturity to June 30, 2030, and lowers the interest margins on revolving loans, which gives the company more borrowing capacity on longer terms and at lower rates.
Revolving commitments increased from $320 million to $400 million.
Maturity extended from January 18, 2028 to June 30, 2030.
SOFR margin range cut to 3.25% to 4.00% from 3.50% to 4.25%, depending on total net leverage ratio; base rate margin cut to 2.25% to 3.00% from 2.50% to 3.25%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.